We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your data protection rights.
The biotech company, Sorrento Therapeutics based in San Diego, claim their antibody stopped coronavirus from entering 100 percent of healthy human cells in petri dish experiments, Fox News reported. Sorrento is collaborating with Mt Sinai School of Medicine in New York to reportedly combine this antibody with others to create a drug.
In a press release, the biotech company said they could produce up to 200,000 doses of the antibody in a month.
This timeframe would make the drug available months before a Covid-19 vaccine is expected.
Sorrento has not yet received the green light from the US Food and Drug Administration, according to the Daily Mail.
Stocks for the company have reportedly surged by nearly 220 percent after the announcement was made.
Speaking to Fox news, Dr Henry Ji, CEO of Sorrento said: “We want to emphasise there is a cure.
“There is a solution that works 100 percent.
“If we have the neutralising antibody in your body, you don’t need the social distancing. You can open up a society without fear.”
The tests in the laboratory were on human cells in a petri dish, the company reportedly hasn’t shown whether it can block infection in the human body.
How the antibody might behave inside a human body and its possible side effects are unknown.
Antibodies neutralise pathogens which includes viruses such as coronavirus.
A mixture of pathogens, which Sorrento’s drug are claiming to achieve, could prevent coronavirus from entering human cells if it were successful.
Dr Ji told Fox News: “This puts its arms around the virus. It wraps around the virus and moves them out of the body.
How a mutation in a new form of coronavirus may be HARDER to vaccinate [UPDATE]
Donald Trump told to become ‘consoling presence’ as US deaths mount [ANALYSIS]
US politician forced to wear bulletproof vests in coronavirus lockdown [INSIGHT]
“When the antibody prevents a virus from entering a human cell, the virus cannot survive.
“If they cannot get into the cell, they cannot replicate. So it means that if we prevent the virus from getting the cell, the virus eventually dies out. The body clears out that virus.”
Sorrento said they had collected billions of antibodies over the past decade which they started screening on coronavirus pathogens as the outbreak exploded.
Many universities and companies across the world have been exploring the use of antibodies to treat coronavirus.
Speaking to Fox News, Dr Ji continued: “Our STI-1499 antibody shows exceptional therapeutic potential and could potentially save lives following receipt of necessary regulatory approvals.
“We at Sorrento are working day and night to complete the steps necessary to get this product candidate approved and available to the waiting public.”
In the US, 87,774 people have died from coronavirus and there are over 1.4 million confirmed cases.
This comes as many states are beginning to ease lockdown rules despite many experts warning relaxing restrictions could trigger a second wave of coronavirus infections.
Sorrento did not specify a start date or plan for human clinical trials.
Currently, there is no proven cure for coronavirus.
Source: Read Full Article